Yang Dan, Tian Wanting, Wang Wei, Zhao Xuan, Wang Chaozhi, Ma Zhufang
Department of Gastroenterology, 3201 Hospital, Hanzhong, China.
Transl Cancer Res. 2025 Feb 28;14(2):1214-1222. doi: 10.21037/tcr-24-1226. Epub 2025 Feb 24.
So far, there are still few studies on the prognostic factors of hepatocellular carcinoma (HCC) patients with macrovascular invasion (MVI) treated with transcatheter arterial chemoembolization (TACE) combined with intensity modulated radiotherapy (IMRT), and no relevant model has been established to predict the prognosis of such patients. Thus, the purpose of this study was to determine the prognostic factors of HCC patients with MVI after treatment with TACE combined with IMRT, and to establish a nomogram model for forecasting 1-, 3-, 5-year overall survival (OS) of the patients.
HCC patients with MVI who were diagnosed and treated at Department of Gastroenterology, 3201 Hospital between January 2010 and December 2020 were enrolled in this study according to the inclusion and exclusion criteria. The risk factors linked to patient OS were determined by performing Cox regression analysis. The nomogram for predicting 1-, 3-, 5-year OS in HCC patients with MVI was stablished and validated based on the results of the Cox regression analysis.
In total, 118 patients were included in the current study. The medium follow-up time was 46 months (range, 29-71 months). Univariate Cox regression analysis revealed that tumor diameter, treatment frequency of TACE, IMRT dose, Child-Pugh grade, liver cirrhosis and alpha fetoprotein (AFP) level were significantly related to the OS of the patients. Further multivariate Cox regression analysis showed that treatment frequency of TACE and Child-Pugh grade, liver cirrhosis and AFP level were the independent prognostic factors of the OS in patients who were treated with TACE combined with IMRT. The nomogram we constructed using the above independent risk factors exhibited good ability for predicting 1-, 3-, 5-year OS of the patients. The concordance-index of the nomogram was 0.727, indicating the nomogram had a good discrimination.
Treatment frequency of TACE and Child-Pugh grade, liver cirrhosis and AFP level were independent predictors of OS in HCC patients with MVI after TACE combined with IMRT treatment. The nomogram that we developed using these predictors provided a convenient tool to predict the survival probability in HCC patients with MVI.
迄今为止,关于经动脉化疗栓塞术(TACE)联合调强放疗(IMRT)治疗的伴有大血管侵犯(MVI)的肝细胞癌(HCC)患者的预后因素的研究仍然较少,且尚未建立相关模型来预测此类患者的预后。因此,本研究的目的是确定TACE联合IMRT治疗后伴有MVI的HCC患者的预后因素,并建立一个列线图模型来预测患者1年、3年、5年的总生存期(OS)。
根据纳入和排除标准,选取2010年1月至2020年12月在3201医院消化内科诊断并接受治疗的伴有MVI的HCC患者纳入本研究。通过进行Cox回归分析确定与患者OS相关的危险因素。基于Cox回归分析的结果,建立并验证了用于预测伴有MVI的HCC患者1年、3年、5年OS的列线图。
本研究共纳入118例患者。中位随访时间为46个月(范围29 - 71个月)。单因素Cox回归分析显示,肿瘤直径、TACE治疗次数、IMRT剂量、Child-Pugh分级、肝硬化和甲胎蛋白(AFP)水平与患者的OS显著相关。进一步的多因素Cox回归分析表明,TACE治疗次数以及Child-Pugh分级、肝硬化和AFP水平是接受TACE联合IMRT治疗患者OS的独立预后因素。我们使用上述独立危险因素构建的列线图对患者1年、3年、5年OS具有良好的预测能力。列线图的一致性指数为0.727,表明列线图具有良好的区分度。
TACE治疗次数以及Child-Pugh分级、肝硬化和AFP水平是TACE联合IMRT治疗后伴有MVI的HCC患者OS的独立预测因素。我们使用这些预测因素开发的列线图为预测伴有MVI的HCC患者的生存概率提供了一个便捷工具。